These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12943819

  • 21. Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin.
    de Bree E, Romanos J, Michalakis J, Relakis K, Georgoulias V, Melissas J, Tsiftsis DD.
    Anticancer Res; 2003; 23(3C):3019-27. PubMed ID: 12926156
    [Abstract] [Full Text] [Related]

  • 22. Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasibility and pharmacokinetic study.
    Fushida S, Kinoshita J, Yagi Y, Funaki H, Kinami S, Ninomiya I, Fujimura T, Nishimura G, Kayahara M, Ohta T.
    Oncol Rep; 2008 May; 19(5):1305-10. PubMed ID: 18425392
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C.
    Sugarbaker PH, Stuart OA, Carmignani CP.
    Cancer Chemother Pharmacol; 2006 May; 57(5):703-8. PubMed ID: 16096789
    [Abstract] [Full Text] [Related]

  • 24. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
    Liu J, Kraut EH, Balcerzak S, Grever M, D'Ambrosio S, Chan KK.
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
    [Abstract] [Full Text] [Related]

  • 25. [Pharmacokinetic study of intraperitoneal chemotherapy with HCPT].
    Ye M, Lin XX, Pan HM, Li N, Lou F, Jin W, Zheng Y, Wu JM.
    Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(20):1610-2. PubMed ID: 16422545
    [Abstract] [Full Text] [Related]

  • 26. Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice.
    van Tellingen O, Beijnen JH, Verweij J, Scherrenburg EJ, Nooijen WJ, Sparreboom A.
    Clin Cancer Res; 1999 Oct; 5(10):2918-24. PubMed ID: 10537361
    [Abstract] [Full Text] [Related]

  • 27. Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer.
    Yonemura Y, Endou Y, Bando E, Kuno K, Kawamura T, Kimura M, Shimada T, Miyamoto K, Sasaki T, Sugarbaker PH.
    Cancer Lett; 2004 Jul 16; 210(2):189-96. PubMed ID: 15183534
    [Abstract] [Full Text] [Related]

  • 28. Liquid chromatography/tandem triple-quadrupole mass spectrometry for determination of paclitaxel in rat tissues.
    Tong X, Zhou J, Tan Y.
    Rapid Commun Mass Spectrom; 2006 Jul 16; 20(12):1905-12. PubMed ID: 16715470
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Taxoids in combination with anthracyclines and other agents: pharmacokinetic considerations.
    D'Incalci M, Schüller J, Colombo T, Zucchetti M, Riva A.
    Semin Oncol; 1998 Dec 16; 25(6 Suppl 13):16-20. PubMed ID: 9865687
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical pharmacokinetics of docetaxel.
    Clarke SJ, Rivory LP.
    Clin Pharmacokinet; 1999 Feb 16; 36(2):99-114. PubMed ID: 10092957
    [Abstract] [Full Text] [Related]

  • 36. Intraperitoneal taxanes.
    Mohamed F, Sugarbaker PH.
    Surg Oncol Clin N Am; 2003 Jul 16; 12(3):825-33. PubMed ID: 14567034
    [Abstract] [Full Text] [Related]

  • 37. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB, Valero V, Hortobagyi G.
    Drug Saf; 2000 Nov 16; 23(5):401-28. PubMed ID: 11085347
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
    Wang T, Cheng HH, Heimbürger O, Waniewski J, Bergström J, Lindholm B.
    Kidney Int; 1998 Feb 16; 53(2):496-502. PubMed ID: 9461112
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.